These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 32279449

  • 1. 99m Tc-(EDDA/tricine)-HYNIC-GnRH analogue as a potential imaging probe for diagnosis of prostate cancer.
    Masteri Farahani A, Maleki F, Sadeghzadeh N, Abediankenari S, Abedi SM, Erfani M.
    Chem Biol Drug Des; 2020 Aug; 96(2):850-860. PubMed ID: 32279449
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a New 99mTc-labeled GnRH Analogue as a Possible Imaging Agent for Prostate Cancer Detection.
    Farahani AM, Maleki F, Sadeghzadeh N, Abediankenari S, Abedi SM, Erfani M.
    Anticancer Agents Med Chem; 2020 Aug; 20(14):1695-1703. PubMed ID: 32560611
    [Abstract] [Full Text] [Related]

  • 3. Preliminary application of micro-SPECT/CT imaging by 99m Tc-tricine-EDDA-HYNIC-c-Met for non-small-cell lung cancer.
    Zhang Y, Meng L, Li B, Tan H, Lin QY, Cheng D, Shi H.
    Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
    Yurt Lambrecht F, Durkan K, Ozgür A, Gündüz C, Avcı CB, Susluer SY.
    J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856
    [Abstract] [Full Text] [Related]

  • 7. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V.
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [Abstract] [Full Text] [Related]

  • 8. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands].
    Hernández-Cairo A, Perera-Pintado A, Prats-Capote A, Batista-Cuellar JF, Casacó-Santana C.
    Rev Esp Med Nucl Imagen Mol; 2012 Apr; 31(2):61-5. PubMed ID: 22305264
    [Abstract] [Full Text] [Related]

  • 9. An improved 99mTc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor.
    Khodadust F, Ahmadpour S, Aligholikhamseh N, Abedi SM, Hosseinimehr SJ.
    Eur J Med Chem; 2018 Jan 20; 144():767-773. PubMed ID: 29291444
    [Abstract] [Full Text] [Related]

  • 10. Tricine co-ligand improved the efficacy of 99mTc-HYNIC-(Ser)3-J18 peptide for targeting and imaging of non-small-cell lung cancer.
    Shaghaghi Z, Abedi SM, Hosseinimehr SJ.
    Biomed Pharmacother; 2018 Aug 20; 104():325-331. PubMed ID: 29775901
    [Abstract] [Full Text] [Related]

  • 11. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ.
    Nucl Med Biol; 2008 May 20; 35(4):401-11. PubMed ID: 18482677
    [Abstract] [Full Text] [Related]

  • 12. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
    Yang X, Li G, Ruan C, Hu K, Tang G.
    Bioconjug Chem; 2023 Nov 15; 34(11):2133-2143. PubMed ID: 37874952
    [Abstract] [Full Text] [Related]

  • 13. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R.
    Nucl Med Biol; 2006 Nov 15; 33(8):945-52. PubMed ID: 17127166
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative assessment of a 99mTc labeled H1299.2-HYNIC peptide bearing two different co-ligands for tumor-targeted imaging.
    Torabizadeh SA, Abedi SM, Noaparast Z, Hosseinimehr SJ.
    Bioorg Med Chem; 2017 May 01; 25(9):2583-2592. PubMed ID: 28351606
    [Abstract] [Full Text] [Related]

  • 16. 99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
    von Guggenberg E, Dietrich H, Skvortsova I, Gabriel M, Virgolini IJ, Decristoforo C.
    Eur J Nucl Med Mol Imaging; 2007 Aug 01; 34(8):1209-18. PubMed ID: 17308920
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [99m Tc-HYNIC/EDDA]-MccJ25 antimicrobial peptide analog as a potential radiotracer for detection of infection.
    Mazaheri Tehrani M, Erfani M, Amirmozafari N.
    Chem Biol Drug Des; 2021 Apr 01; 97(4):904-913. PubMed ID: 33326679
    [Abstract] [Full Text] [Related]

  • 19. [99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor.
    Kaihani S, Sadeghzadeh N, Abediankenari S, Abedi SM.
    Ann Nucl Med; 2022 Nov 01; 36(11):976-985. PubMed ID: 36097232
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.